Table 4.
Albumin (g/L) |
Univariate HR* (95% CI) |
P value |
Multivariate† HR* (95% CI) |
P value |
|
---|---|---|---|---|---|
Race | |||||
White (N=1707) | 39.9 (0.31) | 1.13 (1.04–1.22) | 0.003 | 1.13 (1.04–1.22) | 0.004 |
Black (N=1200) | 39.6 (0.31) | 1.14 (1.06–1.23) | 0.001 | 1.13 (1.04–1.22) | 0.003 |
Gender | |||||
Male (N=1394) | 40.0 (0.32) | 1.14 (1.06–1.23) | 0.001 | 1.13 (1.05–1.23) | 0.002 |
Female (N=1513) | 39.6 (0.30) | 1.14 (1.05–1.23) | 0.001 | 1.12 (1.04–1.22) | 0.005 |
HR: hazard ratio per -1g/L baseline albumin concentration
Multivariate model including clinical predictors of heart failure, inflammatory markers, and incident coronary events
Interaction for race: univariate, P=0.72; multivariate, P=0.97
Interaction for gender: univariate, P=0.86; multivariate, P=0.82
The time-dependent decrease in the albumin hazard ratio over time was similar across all race- and gender-based subgroups, diminishing by approximately 2.0% per year (95% CI, 1.7–2.3)